Long-term leptin-replacement therapy for lipoatrophic diabetes [5]

New England Journal of Medicine

Volumn 351, Issue 6, 2004, Pages 615-616

  Ebihara, Ken ^a   Masuzaki, Hiroaki ^a   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; GLYCOSYLATED HEMOGLOBIN; LEPTIN; TRIACYLGLYCEROL;

BODY FAT; DIET RESTRICTION; DUAL ENERGY X RAY ABSORPTIOMETRY; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; LETTER; LIPOATROPHIC DIABETES MELLITUS; PRIORITY JOURNAL; SUBSTITUTION THERAPY; ADULT; BLOOD; CHILD; DRUG EFFECT; FEMALE; HISTOLOGY; HUMAN; LIVER; MALE; NOTE;

ADULT; CHILD; DIABETES MELLITUS, LIPOATROPHIC; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTRIGLYCERIDEMIA; LEPTIN; LIVER; MALE; TRIGLYCERIDES;

EID: 3442878960     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200408053510623     Document Type: Letter

References (1)

1. Oral EA, Simha V, Ruiz E, et al. Leptin-replacement therapy for lipodystrophy. N Engl J Med 2002;346:570-8.